HTF Market Intelligence released a new research report of 30 pages on title 'Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile' with detailed analysis, forecast and strategies.

Summary

Transgene SA (Transgene) is a biopharmaceutical company that focuses on the discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company’s lead clinical stage programs include TG4010, which is intended for the treatment of non small cell lung cancer and PexaVec, for liver cancer. It also has various other programs in clinical and pre clinical development including TG4001, for HIV positive cancers; TG1050, for chronic hepatitis B; and TG6002, for glioblastoma. The company has a presence in the US and China. Transgene is headquartered in Illkirch Graffenstaden, France.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/254137-transgene-sa-2

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

The derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/254137-transgene-sa-2


Table of Contents

List of Tables 3
List of Figures 4
Transgene SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Transgene SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Transgene SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Transgene SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Transgene SA, Medical Devices Deals, 2011 to YTD 2017 9
Transgene SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Transgene SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Jennerex Biotherapeutics Raises US$21.6 Million In Venture Financing 11
ElsaLys Biotech Raises US$2.7 Million In First Round Of Financing 11
Partnerships 13
Transgene Enters into Agreement with Merck and Pfizer 13
Transgene and SillaJen Amends Agreement 14

……………Continued


Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=254137

Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
[email protected]
Ph: +1 (206) 317 1218